Evidence map›Paper›PMID 38607928›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2024

Assessing the Impact of the 2020 Council of State and Territorial Epidemiologists Case Definition for Pertussis on Reported Pertussis Cases.

Amy B Rubis, Matthew Cole, M Lucia Tondella, Lucia C Pawloski, Erin Youngkin, Patricia Firmender, Vanessa Aden, Victor Cruz, Emma Stanislawski, Rachel Wester and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 1 country.

Amy B RubisMeningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Matthew ColeMeningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
M Lucia TondellaMeningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Lucia C PawloskiMeningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Erin YoungkinColorado Department of Public Health and Environment, Denver, Colorado, USA.
Patricia FirmenderConnecticut Department of Public Health, Hartford, Connecticut, USA.
Vanessa AdenGeorgia Department of Public Health, Atlanta, Georgia, USA.
Victor CruzMinnesota Department of Public Health, St. Paul, Minnesota, USA.
Emma StanislawskiNew Mexico Department of Health, Santa Fe, New Mexico, USA.
Rachel WesterNew York State Department of Public Health, Albany, New York, USA.
Paul R CieslakOregon Health Authority, Portland, Oregon, USA.
Anna M AcostaMeningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA (now with GSK Vaccines).
Tami H SkoffMeningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Centers for Disease Control and Prevention · USNational Center for Immunization and Respiratory Diseases · USColorado Department of Public Health and Environment · USConnecticut Department of Public Health · USGeorgia Department of Public Health · USMinnesota Department of Health · USNew Mexico Department of Health · USNew York State Department of Health · USOregon Health Authority · US

Funding

CDC HHSIntramural CDC HHS CC999999
6 · The paper itself

Abstract

backgroundIn 2020, the Council of State and Territorial Epidemiologists (CSTE) pertussis case definition was modified; the main change was classifying polymerase chain reaction (PCR)-positive cases as confirmed, regardless of cough duration. Pertussis data reported through Enhanced Pertussis Surveillance (EPS) in 7 sites and the National Notifiable Diseases Surveillance System (NNDSS) were used to evaluate the impact of the new case definition.

methodsWe compared the number of EPS cases with cough onset in 2020 to the number that would have been reported based on the prior (2014) CSTE case definition. To assess the impact of the change nationally, the proportion of EPS cases newly reportable under the 2020 CSTE case definition was applied to 2020 NNDSS data to estimate how many additional cases were captured nationally.

resultsAmong 442 confirmed and probable cases reported to EPS states in 2020, 42 (9.5%) were newly reportable according to the 2020 case definition. Applying this proportion to the 6124 confirmed and probable cases reported nationally in 2020, we estimated that the new definition added 582 cases. Had the case definition not changed, reported cases in 2020 would have decreased by 70% from 2019; the observed decrease was 67%.

conclusionsDespite a substantial decrease in reported pertussis cases in the setting of coronavirus disease 2019 (COVID-19), our data show that the 2020 pertussis case definition change resulted in additional case reporting compared with the previous case definition, providing greater opportunities for public health interventions such as prophylaxis of close contacts.

Indexed as

Bordetella pertussisWhooping CoughAdolescentAdultChildChild, PreschoolDisease NotificationFemaleHumansInfantMalePolymerase Chain ReactionPopulation SurveillanceUnited StatesYoung Adultcase definitionnationally notifiablepertussissurveillancevaccine-preventable

Identifiers

PMID38607928
PMCPMC11302466
OpenAlexW4394789560

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.